SRC and thyroid gland carcinoma: In support of this data, multiple laboratories have demonstrated that the combined inhibition of Src and the MAPK pathway results in synergistic inhibition of growth and increased apoptosis of thyroid cancer cells both in vitro and in vivo10–12.